Insuline Medical (Israel) Investor Sentiment

INSL Stock  ILS 196.00  20.90  9.64%   
About 61% of Insuline Medical's investor base is looking to short. The analysis of current outlook of investing in Insuline Medical suggests that many traders are alarmed regarding Insuline Medical's prospects. The current market sentiment, together with Insuline Medical's historical and current headlines, can help investors time the market. In addition, many technical investors use Insuline Medical stock news signals to limit their universe of possible portfolio assets.
  
over a month ago at news.google.com         
Modular Medical Launches Public Offering of Common Stock, Pre-Funded Warrants MODD Stock News - Stoc...
Google News at Macroaxis
over three months ago at news.google.com         
FTC Sues CVS, Cigna, UnitedHealth Over Insulin Costs - Marketscreener.com
Google News at Macroaxis
over three months ago at news.google.com         
Modular Medical Announces Issuance of U.S. Patent Covering Key Aspects of Core Pumping Technology - ...
Google News at Macroaxis
over three months ago at news.google.com         
Modular Medical Announces FDA Clearance of the MODD1 Insulin Pump - StockTitan
Google News at Macroaxis
over three months ago at news.google.com         
Registration is Now Open for Tribe Publics Webinar Event Diabetes Care Innovator Modular Medical Tak...
Google News at Macroaxis
over three months ago at news.google.com         
Modular Medical Initiates Transfer of Manufacturing Operations to Phillips Medisize - StockTitan
Google News at Macroaxis
over three months ago at news.google.com         
Tandem Diabetes Care and Dexcom Announce the tslim X2 Insulin Pump with Dexcom G7 CGM Compatibility ...
Google News at Macroaxis
over three months ago at news.google.com         
Sanofi eyes German insulin investment of up to 1.6 bln, source says - Reuters
Google News at Macroaxis
over six months ago at news.google.com         
Novo Nordisks Insulin Pen Shortage Impacts Thousands in South Africa - MSF Southern Africa
Google News at Macroaxis
over six months ago at news.google.com         
Alarm over insulin shortage as Brits battling type 1 diabetes fear theyll die within days without ac...
Google News at Macroaxis
over six months ago at news.google.com         
7 Diabetes and Weight Loss Drug Stocks for 2024 Investing - U.S News World Report Money
Google News at Macroaxis
over six months ago at news.google.com         
Best portable insulin coolers 6 picks to store insulin safely - Health shots
Google News at Macroaxis
over six months ago at news.google.com         
Research shows low-fat vegan diet beneficial for type 1 diabetics, reduces insulin dependence - The ...
Google News at Macroaxis
over six months ago at news.google.com         
What to Know About Shortages for Humalog and Insulin Lispro Injection - diaTribe Foundation
Google News at Macroaxis
over six months ago at news.google.com         
Revolutionary chocolate insulin could replace needles for diabetes treatment - Study Finds
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Insuline Medical that are available to investors today. That information is available publicly through Insuline media outlets and privately through word of mouth or via Insuline internal channels. However, regardless of the origin, that massive amount of Insuline data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Insuline Medical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Insuline Medical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Insuline Medical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Insuline Medical alpha.

Insuline Medical Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Insuline Stock analysis

When running Insuline Medical's price analysis, check to measure Insuline Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insuline Medical is operating at the current time. Most of Insuline Medical's value examination focuses on studying past and present price action to predict the probability of Insuline Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insuline Medical's price. Additionally, you may evaluate how the addition of Insuline Medical to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Money Managers
Screen money managers from public funds and ETFs managed around the world
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance